Western Superconducting Technologies (688122) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
16 Dec, 2025Executive summary
Revenue for H1 2025 reached ¥2.72 billion, up 34.76% year-over-year, with net profit attributable to shareholders at ¥546 million, up 56.72%.
All three core business segments—superconducting products, high-end titanium alloys, and high-performance superalloys—achieved strong growth, with superconducting products up 65.75%, titanium alloys up 22.06%, and high-temperature alloys up 56.68% year-over-year.
The company continued to invest in R&D, maintaining a high level of innovation and technical leadership, and received multiple national and provincial awards.
Cash flow from operating activities increased 77.73% year-over-year to ¥204 million, driven by higher sales collections.
Financial highlights
Operating income: ¥2.72 billion, up 34.76% year-over-year.
Net profit attributable to shareholders: ¥546 million, up 56.72% year-over-year.
Gross margin improved due to increased product sales and higher profitability.
Basic and diluted EPS: ¥0.8407, up 56.73% year-over-year.
Cash flow from operations: ¥204 million, up 77.73% year-over-year.
Total assets at June 30, 2025: ¥14.71 billion, up 8.09% from year-end 2024.
Outlook and guidance
The company is accelerating digital and intelligent manufacturing upgrades and expects continued growth in all major business lines.
Focus remains on expanding domestic and international markets, maintaining R&D leadership, and supporting national strategic needs.
Latest events from Western Superconducting Technologies
- Double-digit revenue growth and higher net profit reflect strong market and operational gains.688122
H2 202416 Dec 2025 - Q3 profit dropped 59% on higher R&D costs, despite 4% revenue growth year-over-year.688122
Q3 202530 Oct 2025 - Revenue and net profit rose sharply year-over-year, but operating cash flow dropped significantly.688122
Q1 202516 Jun 2025 - Q3 net profit jumped 58% year-over-year on strong revenue and government subsidies.688122
Q3 202413 Jun 2025 - H1 2024 net profit fell 17.24% as revenue declined and R&D investment surged.688122
H1 202413 Jun 2025